Quick Answer
AVITA Medical, Inc. reported R&D Expense of $20.84 million for fiscal year 2025.
AVITA Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $20.84M | +2.4% |
| 2024 | $20.36M | -2.2% |
| 2023 | $20.82M | +50.3% |
| 2022 | $13.86M | -6.5% |
| 2021 | $14.82M | +61.7% |
| 2020 | $9.16M | +14.5% |
| 2019 | $8.00M | +27.9% |
| 2018 | $6.26M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.75M | -31.0% | -26.8% |
| June 30, 2025 | $5.12M | +4.7% | -18.6% |
| March 31, 2025 | $6.28M | +21.0% | +15.8% |
| September 30, 2024 | $5.43M | +23.5% | +11.1% |
| June 30, 2024 | $4.89M | -3.7% | -5.9% |
| March 31, 2024 | $5.19M | +13.3% | +18.2% |
| September 30, 2023 | $4.39M | +15.7% | -13.4% |
| June 30, 2023 | $5.08M | +65.9% | +10.7% |
- AVITA Medical, Inc. showed an increase of +2.4% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, AVITA Medical, Inc.’s r&d expense has grown by 233.1% (from $6.26 million to $20.84 million).
- The most recent figure is from AVITA Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: